Literature DB >> 23054658

Communication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injury.

Slava Epelman1, Douglas L Mann.   

Abstract

Ischemic cardiac injury is the leading cause of heart failure and mortality in the USA and is a major expense to health-care systems. Once the heart is injured, a highly dynamic and coordinated immune response is initiated, which is dependent on both resident and recruited leukocytes. The goal of the inflammatory response is to remove ischemic and necrotic material and to promote infarct healing. If this system is perturbed, the myocardium heals poorly, leading to significant left ventricular dysfunction. Understanding how inflammatory cells coordinate and interact with each other is required prior to designing therapeutic interventions that target pathological processes at play and leave untouched those processes that are protective. This review will discuss the intercellular cross talk between cells of the innate immune system following myocardial ischemic injury and how that response is coordinated over time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054658      PMCID: PMC3847667          DOI: 10.1007/s12265-012-9410-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  65 in total

1.  Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and α4β7 integrin expression by NK cells.

Authors:  Manaf Bouchentouf; Kathy-Ann Forner; Jessica Cuerquis; Véronique Michaud; Jiamin Zheng; Pierre Paradis; Ernesto L Schiffrin; Jacques Galipeau
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 2.  Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.

Authors:  Jason J Gajarsa; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

3.  Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes.

Authors:  Scott D Kobayashi; Jovanka M Voyich; Kevin R Braughton; Frank R DeLeo
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction.

Authors:  Florian Leuschner; Peter Panizzi; Isabel Chico-Calero; Won Woo Lee; Takuya Ueno; Virna Cortez-Retamozo; Peter Waterman; Rostic Gorbatov; Brett Marinelli; Yoshiko Iwamoto; Aleksey Chudnovskiy; Jose-Luiz Figueiredo; David E Sosnovik; Mikael J Pittet; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf
Journal:  Circ Res       Date:  2010-10-07       Impact factor: 17.367

5.  An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation.

Authors:  Scott D Kobayashi; Jovanka M Voyich; Greg A Somerville; Kevin R Braughton; Harry L Malech; James M Musser; Frank R DeLeo
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

6.  Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis.

Authors:  Claudia Waskow; Sabine Paul; Corinne Haller; Max Gassmann; Hans-Reimer Rodewald
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

7.  IL-17F/IL-17R interaction stimulates granulopoiesis in mice.

Authors:  Weihong Tan; Weitao Huang; Xiaogang Gu; Qiu Zhong; Bainan Liu; Paul Schwarzenberger
Journal:  Exp Hematol       Date:  2008-08-23       Impact factor: 3.084

8.  Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion.

Authors:  Benjamin J Capoccia; Alyssa D Gregory; Daniel C Link
Journal:  J Leukoc Biol       Date:  2008-06-11       Impact factor: 4.962

9.  Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?

Authors:  Elena Kaschina; Aleksandra Grzesiak; Jun Li; Anna Foryst-Ludwig; Melanie Timm; Franziska Rompe; Manuela Sommerfeld; U Rudolf Kemnitz; Caterina Curato; Pawel Namsolleck; Carsten Tschöpe; Anders Hallberg; Mathias Alterman; Thomas Hucko; Ingo Paetsch; Thore Dietrich; Bernhard Schnackenburg; Kristof Graf; Björn Dahlöf; Ulrich Kintscher; Thomas Unger; U Muscha Steckelings
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

Review 10.  Innate immune mechanisms in ischemia/reperfusion.

Authors:  David J Kaczorowski; Allan Tsung; Timothy R Billiar
Journal:  Front Biosci (Elite Ed)       Date:  2009-06-01
View more
  12 in total

1.  Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction.

Authors:  Tongqing Yao; Wenbin Lu; Jian Zhu; Xian Jin; Genshan Ma; Yuepeng Wang; Shu Meng; Yachen Zhang; Yigang Li; Chengxing Shen
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.

Authors:  Bochra Tourki; Ganesh Halade
Journal:  FASEB J       Date:  2017-06-22       Impact factor: 5.191

3.  Prognostic Value of Neutrophil to Lymphocyte Ratio for In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction.

Authors:  Tang-Meng Guo; Bei Cheng; Li Ke; Si-Ming Guan; Ben-Ling Qi; Wen-Zhu Li; Bin Yang
Journal:  Curr Med Sci       Date:  2018-04-30

Review 4.  Role of inflammatory cells in fibroblast activation.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2015-11-20       Impact factor: 5.000

Review 5.  Integrins and integrin-related proteins in cardiac fibrosis.

Authors:  Chao Chen; Ruixia Li; Robert S Ross; Ana Maria Manso
Journal:  J Mol Cell Cardiol       Date:  2015-11-10       Impact factor: 5.000

6.  Pathological ventricular remodeling: therapies: part 2 of 2.

Authors:  Min Xie; Jana S Burchfield; Joseph A Hill
Journal:  Circulation       Date:  2013-08-27       Impact factor: 29.690

7.  The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy.

Authors:  András Mihály Boros; Gábor Széplaki; Péter Perge; Zsigmond Jenei; Zsolt Bagyura; Endre Zima; Levente Molnár; Astrid Apor; Dávid Becker; László Gellér; Zoltán Prohászka; Béla Merkely
Journal:  Europace       Date:  2015-05-12       Impact factor: 5.214

8.  11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI.

Authors:  Katie J Mylonas; Neil A Turner; Sumia A Bageghni; Christopher J Kenyon; Christopher I White; Kieran McGregor; Robert A Kimmitt; Richard Sulston; Valerie Kelly; Brian R Walker; Karen E Porter; Karen E Chapman; Gillian A Gray
Journal:  J Endocrinol       Date:  2017-06       Impact factor: 4.286

9.  (Re) Solving Repair After Myocardial Infarction.

Authors:  Giovanna Leoni; Oliver Soehnlein
Journal:  Front Pharmacol       Date:  2018-11-26       Impact factor: 5.810

10.  Immune-Inflammatory Activation in Acute Coronary Syndromes: A Look into the Heart of Unstable Coronary Plaque.

Authors:  Giovanni Cimmino; Francesco S Loffredo; Alberto Morello; Saverio D'Elia; Raffaele De Palma; Plinio Cirillo; Paolo Golino
Journal:  Curr Cardiol Rev       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.